World's Best Scientists 2026 revealed!
Arnold L. Demain

Arnold L. Demain

D-Index & Metrics

Biology and Biochemistry

D-Index
87
Citations
34089
World Ranking
2788
National Ranking
1436

Overview

Arnold L. Demain was affiliated with Drew University in the United States. Their research covered several fields of study including Medicine, Biochemistry, Genetics and Molecular Biology, and Pharmacology, Toxicology and Pharmaceutics.

Their work focused particularly on subfields such as Pharmacology and Molecular Biology. The main topics addressed in their research included Microbial Natural Products and Biosynthesis, vaccines and immunoinformatics approaches, and Pharmacogenetics and Drug Metabolism.

Demain's publications appeared in specialized venues. Notably, they had works published in:

  • Applied Microbiology and Biotechnology

One of the recent papers authored under their name was titled "Impact of novel microbial secondary metabolites on the pharma industry", published in 2022 in Applied Microbiology and Biotechnology.

Frequent collaborators of Arnold L. Demain included:

  • David S. Goodsell
  • G. M. Halpern
  • Ananda M. Chakrabarty
  • David P. Clark
  • Stefan Dübel

These coauthors worked with Demain on multiple occasions, indicating a pattern of repeated scientific collaboration.

Best Publications

  • Production of recombinant proteins by microbes and higher organisms.

    Arnold L. Demain;Preeti Vaishnav

  • Microbial drug discovery: 80 years of progress

    Arnold L Demain;Sergio Sanchez

  • Cellulase, Clostridia, and Ethanol

    Arnold L. Demain;Michael Newcomb;J. H. David Wu

  • MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY

    A.L Demain;J.E Davies

  • The natural functions of secondary metabolites.

    Arnold L. Demain;Aiqi Fang

  • The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions.

    E Katz;A L Demain

  • Microbial Enzymes: Tools for Biotechnological Processes

    Jose L. Adrio;Arnold L. Demain

  • NATURAL PRODUCTS FOR CANCER CHEMOTHERAPY

    Arnold L. Demain;Preeti Vaishnav

  • Control of antibiotic biosynthesis.

    J F Martin;A L Demain

  • Pharmaceutically active secondary metabolites of microorganisms.

    A. L. Demain

  • Manual of industrial microbiology and biotechnology.

    R. H. Baltz;J. E. Davies;A. L. Demain

  • XPB, a subunit of TFIIH, is a target of the natural product triptolide

    Denis V. Titov;Benjamin Gilman;Qing Li He;Shridhar Bhat

  • The antibiotic resistance crisis, with a focus on the United States

    Evan Martens;Arnold L Demain

  • Importance of microbial natural products and the need to revitalize their discovery

    Arnold L. Demain

  • Fermentation and Enzyme Technology

    Charles L. Cooney;Arnold L. Demain

  • Saccharification of Complex Cellulosic Substrates by the Cellulase System from Clostridium thermocellum.

    Eric A. Johnson;Mitsuji Sakajoh;Geoffrey Halliwell;Ashwin Madia

  • Effect of primary metabolites on secondary metabolism.

    Stephen W. Drew;Arnold L. Demain

  • Small bugs, big business: The economic power of the microbe

    Arnold L Demain

  • Metabolic regulation of fermentation processes

    Sergio Sanchez;Arnold L Demain

  • Fungal biotechnology

    Jose L. Adrio;Arnold L. Demain

Frequent Co-Authors

Saul Wolfe
Saul Wolfe Simon Fraser University
Susan E. Jensen
Susan E. Jensen University of Alberta
Armin Fiechter
Armin Fiechter ETH Zurich
Mary F. Roberts
Mary F. Roberts Boston College
Alfredo F. Braña
Alfredo F. Braña University of Oviedo
James C. Weaver
James C. Weaver Cornell University
Yuval Shoham
Yuval Shoham Technion – Israel Institute of Technology
Lee R. Lynd
Lee R. Lynd Dartmouth College
Juan F. Martín
Juan F. Martín University of Leon
Jack E. Baldwin
Jack E. Baldwin University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Arnold L. Demain